A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin (MEGMI‐CGM study)

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 26; no. 8; pp. 3471 - 3474
Main Authors Takahashi, Akihiro, Nomoto, Hiroshi, Onishi, Kinnosuke, Manda, Satoru, Miya, Aika, Kameda, Hiraku, Nakamura, Akinobu, Atsumi, Tatsuya
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2024
Wiley Subscription Services, Inc
Subjects
Aged
Antidiabetics
Blood Glucose - analysis
Blood Glucose - drug effects
Blood Glucose - metabolism
Clinical outcomes
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Dose-Response Relationship, Drug
Drug dosages
Drug Therapy, Combination
Female
Glycated Hemoglobin - analysis
Glycated Hemoglobin - drug effects
Glycated Hemoglobin - metabolism
Glycemic Control - methods
Humans
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - therapeutic use
Male
Metformin
Metformin - administration & dosage
Metformin - therapeutic use
Middle Aged
Online AccessGet full text

Cover

More Information
Bibliography:Akihiro Takahashi and Hiroshi Nomoto contributed equally.
SourceType-Scholarly Journals-1
ObjectType-Correspondence-2
content type line 14
ObjectType-Letter to the Editor-1
ObjectType-Feature-2
ObjectType-Correspondence-1
content type line 23
ObjectType-Article-3
ObjectType-Undefined-4
ISSN:1462-8902
1463-1326
1463-1326
DOI:10.1111/dom.15639